Detalus Advisors
ABBV icon

Detalus Advisors’s AbbVie ABBV Stock Holding History

Detalus Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.78M Buy
14,467
+86
+0.6% +$22K 0.75% 29
2026
Q2 		$3.62M Sell
14,381
-275
-2% -$59.2K 0.71% 32
2026
Q1 		$3.19M Sell
14,656
-63
-0.4% -$14K 0.73% 30
2025
Q4 		$3.36M Sell
14,719
-7
-0% -$1.6K 0.82% 25
2025
Q3 		$3.41M Buy
14,726
+25
+0.2% +$5.09K 0.88% 24
2025
Q2 		$2.73M Buy
14,701
+2
+0% +$372 0.79% 28
2025
Q1 		$3.08M Buy
14,699
+65
+0.4% +$12.6K 0.97% 25
2024
Q4 		$2.6M Buy
14,634
+36
+0.2% +$6.62K 0.86% 25
2024
Q3 		$2.88M Buy
14,598
+44
+0.3% +$8.21K 0.96% 21
2024
Q2 		$2.5M Sell
14,554
-1,451
-9% -$240K 0.86% 22
2024
Q1 		$2.91M Sell
16,005
-124
-0.8% -$21.4K 1.04% 22
2023
Q4 		$2.5M Sell
16,129
-400
-2% -$58.3K 1% 21
2023
Q3 		$2.46M Sell
16,529
-200
-1% -$29.4K 1.15% 17
2023
Q2 		$2.25M Buy
16,729
+224
+1% +$32.8K 1.01% 19
2023
Q1 		$2.63M Sell
16,505
-994
-6% -$152K 1.26% 17
2022
Q4 		$2.83M Buy
17,499
+13,785
+371% +$2.11M 1.38% 16
2022
Q3 		$498K Sell
3,714
-100
-3% -$14.4K 0.3% 66
2022
Q2 		$584K Hold
3,814
– – 0.34% 56
2022
Q1 		$618K Sell
3,814
-2,400
-39% -$349K 0.33% 52
2021
Q4 		$841K Sell
6,214
-90
-1% -$10.6K 0.4% 41
2021
Q3 		$680K Buy
6,304
+350
+6% +$40K 0.35% 50
2021
Q2 		$671K Buy
+5,954
New +$671K 0.36% 50
2020
Q3 		– Sell
-2,474
Closed -$243K – 90
2020
Q2 		$243K Buy
+2,474
New +$218K 0.19% 80
2020
Q1 		– Sell
-2,425
Closed -$215K – 87
2019
Q4 		$215K Buy
+2,425
New +$201K 0.16% 93

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Detalus Advisors's ABBV Position: Q3 2026 in Review

Detalus Advisors increased its AbbVie (ABBV) stake by 0.6% in Q3 2026, buying an estimated $22K and bringing the position to 14,467 shares worth $3.78M. The position accounts for 0.75% of the portfolio, ranked #29.

Detalus Advisors first reported a position in ABBV in Q4 2019 and has held it in 24 quarters since. 2,709 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Detalus Advisors held 14,467 shares of AbbVie worth $3.78M as of Q3 2026.
  • Detalus Advisors bought 86 AbbVie shares in Q3 2026, an estimated $22K.
  • AbbVie made up 0.75% of Detalus Advisors's portfolio in Q3 2026, its #29 holding.
  • Detalus Advisors first reported a position in AbbVie in Q4 2019 and has held it in 24 quarters since.
  • 2,709 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Detalus Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.